The national medicines authority (Infarmed) announced today that it has suspended the sale and withdrawn from the market Nuud brand deodorant following cases reported in France of temporary underarm inflammation.
According to an information circular issued by Infarmed on Friday, but only released today, the manufacturer of the deodorant, together with the French drug safety agency, “decided to proceed with the voluntary and temporary recall of the batches that are on the market” after having “detected some cases of the appearance of temporary axillary inflammation” that may be related to the use of the cosmetic.
Although “no similar case has been reported in Portugal”, Infarmed – the National Authority for Medicines and Health Products – believes that the measure adopted in France “should be extended to the national territory”.
After contacting the distributor of the Nuud brand registered in Portugal, Infarmed determined that the deodorant “cannot be marketed”, that “entities that have this product should not make it available” and that consumers “who have these products should avoid using them”.
Infarmed asks people to report any symptoms related to the use of Nuud brand deodorant via the Online Services/Report.
In France, the order to suspend the sale and withdraw the deodorant from the market was issued on Wednesday, following complaints of painful sebaceous cysts appearing in the armpits.
